Accrued Expenses and Other Current Liabilities

12 Months Ended

Dec. 31, 2020

Accrued Liabilities [Abstract]

Accrued Expenses and Other Current Liabilities

Note 6 — Accrued Expenses and Other Current Liabilities

Accrued expenses and Other Current Liabilities consist of the following items as of December 31, 2020 and 2019:

	December 31, 2020		December 31, 2019
Compensation and Employee Benefits	$	1,777	$	1,074
CWRU License Agreement fee		223		223
CWRU License Agreement Amendment fee		100		—
Operating expenses		171		89
EsoGuard supplies		22		—
CarpX devices		32		—
Total accrued expenses and other current liabilities	$	2,325	$	1,386

The “Compensation and Employee Benefits” includes: the guaranteed bonus payment under the Company’s Chief Executive Officer (“CEO”) Employment Agreement; discretionary bonus payments to other employees; unused employee vacation time; and employee payroll deductions related to the PAVmed Inc. Employee Stock Purchase Plan (“PAVmed Inc. ESPP”). See Note 11, Stock-Based Compensation, for additional information on the PAVmed Inc. ESPP.

The CWRU License Agreement license fee was approximately $273, of which $50 was previously paid. The remaining balance of the license fee is to be paid in quarterly installments of $50, until the license fee is paid-in-full, provided, however, the commencement of the quarterly payments is subject to Lucid Diagnostics Inc. consummation of a bona fide financing with an unrelated third-party in excess of $0.5 million. See Note 3, Agreements Related to Acquired Intellectual Property Rights - Patent License Agreement - CWRU, for a discussion of the CWRU License Agreement.

The amounts for operating expenses, EsoGuard supplies, and CarpX devices relate to respective amounts incurred by the Company but not yet invoiced by the respective vendors.